Browse > Article
http://dx.doi.org/10.5393/JAMCH.2010.35.1.077

Medical Expenditure Attributable to Overweight and Obesity in Adults with Hypertension, Diabetes and Dyslipidemia : Evidence from Korea National Health and Nutrition Examination Survey Data and Korea National Health Corporation Data  

Kang, Jae-Heon (Department of Family Medicine, Seoul Paik Hospital, College of Medicine, Inje University)
Jeong, Baek-Geun (Department of Preventive Medicine, College of Medicine, Gyeongsang National University & Institute of Health Science)
Cho, Young-Gyu (Department of Family Medicine, Seoul Paik Hospital, College of Medicine, Inje University)
Song, Hye-Ryoung (Department of Family Medicine, College of Medicine, Eulji University)
Kim, Kyung-A (Institute for Clinical Nutrition, Inje University)
Publication Information
Journal of agricultural medicine and community health / v.35, no.1, 2010 , pp. 77-88 More about this Journal
Abstract
Objectives: This study was conducted to estimate medical expenditure attributable to overweight and obesity in adults with hypertension, diabetes and dyslipidemia using Korea National Health and Nutrition Examination survey data and Korea National Health Corporation data. Methods: The medical expenditure of hypertension, diabetes and dyslipidemia related to overweight and obesity were composed of inpatient care costs, outpatient care costs and medication costs. The population attributable risk (PAR) of overweight and obesity was calculated from national representative data of Korea such as the National Health Insurance Corporation cohort data and 2005 Korea National Health and Nutrition Examination survey data. Results: The medical expenditure attributable to overweight and obesity of hypertension were 456 billion won (men : 215 billion won, women : 241 billion won). Those of diabetes were 282 billion won (men : 148 billion won, women : 135 billion won), and of dyslipidemia were 17 billion won (men : 9 billion won, women : 8 billion won). Consequently, these costs corresponded to 33.3% of total medical expenditure due to hypertension, diabetes and dyslipidemia. Conclusions: We found a substantial medical expenditure due to overweight and obesity of hypertension, diabetes and dyslipidemia were very high. In order to reduce these costs, effective national strategies for prevention and management of overweight and obesity should be established and implemented.
Keywords
Obesity; Hypertension; Diabetes; Dyslipidemia; Expenditure;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Thompson D, Wolf AM. The medical-care cost burden of obesity. Obes Rev 2001;2:189-97.   DOI
2 Sturm R. The effects of obesity, smoking, and drinking on medical problems and costs. Health Aff(Millwood) 2002;21(2):245-53.   DOI
3 Khan LK, Sobush K, Keener D, Goodman K, Lowry A, Kakietek J, Zaro S. Recommended community strategies and measurements to prevent obesity in the United States. MMWR Recomm Rep. 2009;58(RR-7):1-26.
4 Kantachuvessiri A. Obesity in Thailand. J Med Assoc Thai 2005;88(4):554-562.
5 Ismail MN, Chee SS, Nawawi H, Yusoff K, Lim TO, James WPT. Obesity in Malaysia. Obes Rev 2002;3(3):203-208.   DOI
6 Ginter E, Simko V. Adult obesity at the beginning of the 21st century: epidemiology, pathophysiology and health risk. Bratisl Lek Listy 2008;109(5):224-230.
7 Kim NS, Moon OR, Kang JH, Lee SY, Jeong BG, Lee SJ, Yoon TH, Hwang KH. Increasing prevalence of obesity related disease for Koreans associated with overweight and obesity. Korean J Prev Med 2001;34(4):309-315(Korean).   과학기술학회마을
8 Bjornelv S, Lydersen S, Holmen J, Lund Nilsen TI, Holmen TL. Sex differences in time trends for overweight and obesity in adolescents: The Young-HUNT study. Scand J Public Health. 2009;37(8):881-889.   DOI
9 Fu T, Wen T, Yeh P, Chang H. Costs of metabolic syndrome - related diseases induced by obesity in Taiwan. Obes Rev. 2008;9 suppl 1:68-73.   DOI
10 Drummond MF. Principles of economic appraisal in health care. Oxford University, 1980, pp10-12.
11 Jarl J, Johansson P, Eriksson A, Eriksson M, Gerdtham U, Hemstro O, Hradilova Selin KH, Lenke L, Ramstedt M, Room R. The societal cost of alcohol consumption: an estimation of the economic and human cost including health effects in Sweden, 2002. Eur J Health Econ 2008;Nov;9(4):351-360.   DOI
12 Hsieh SD, Yoshinaga H. Abdominal fat distribution and coronary heart disease risk factors in men-waist/height ratio as a simple and useful predictor. Int J Obes Relat Metab Disord 1995;19:585-589.
13 Casado V, Romero L, Gubieras L, Alonso L, Moral E, Martinez-Yelamos S, Martinez-Yelamos A, Carmona O, Arbizu T. An approach to estimating the intangible costs of multiple sclerosis according to disability in Catalonia, Spain. Multiple Sclerosis 2007;13:800-804.   DOI
14 Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
15 Hsieh SD, Yoshinaga H. Waist/height ratio as a simple and useful predictor of coronary heart disease risk factors in women. Intern Med 1995;34:1147-1152.   DOI
16 United States. Dept. of Health and Human Services. Healthy people 2010: understanding and improving health. Rev. ed. Boston: Jones and Bartlett Publishers; 2001.
17 서미경, 김혜련, 서동우, 선우덕, 신윤정, 최은진, 최정수, 황나미. 새국민건강증진계획수립. 보건복지부, 한국보건사회연구원; 2006, 305-323쪽
18 보건복지가족부 질병정책과. 2009년도 주요 만성질환관리사업 안내; 2009.
19 Swinburn B, Ashton T, Gillespie J, Cox B, Menon A, Simmons D, Birkbeck J. Health care costs of obesity in New Zealand. Int J Obes Relat Metab Disord 1997;21(10):891-896.   DOI
20 Birmingham CL, Muller JL, Palepu A, Spinelli JJ, Anis AH. The cost of obesity in Canada. CMAJ 1999;160:483-488.
21 Zhao W, Zhai Y, Hu J, Wang J, Yang Z, Kong L, Chen C. Economic burden of obesity-related chronic diseases in Mainland China. Obes Rev. 2008;9 Suppl 1:62-67.   DOI
22 WHO. Obesity-preventing and managing the global epidemic. World Health Organization: Geneva, 1997.
23 Jeong BG, Moon OR, Kim NS, Kang JH, Yoon TH, Lee SY, Lee SJ. Socioeconomic costs of obesity for Korean adults. Korean J Prev Med 2002;35(1):1-12(Korean).   과학기술학회마을
24 김정희, 정종찬, 이호용, 최숙자, 이진경. 2005년도 건강보험환자의 본인부담 진료비 실태조사. 국민건강보험공단; 2006.
25 Bonow RO, Smaha LA, Smith SC Jr, Mensah GA, Lenfant C. World Heart Day 2002: the international burden of cardiovascular disease: responding to the emerging global epidemic. Circulation 2002;106:1602-1605.   DOI
26 Park SH, Choi SJ, Lee KS, Park HY. Waist circumference and waist-to-height ratio as predictors of cardiovascular disease risk in Korean adults. Circ J 2009;73:1643-1650.   DOI
27 Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM. Prevalence of overweight and obesity among US children, adolscent, and adults, 1999-2002. JAMA 2004;291:2847-2850.   DOI
28 Finkelstein EA, Fiebelkorn IC, Wang G. National medical spending attributable to overweight and obesity: how much, and who's paying? Health Aff 2003;Suppl Web Exclusives:W3-219-26.   DOI
29 Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: A 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983;67:968-977.   DOI
30 Alberti KG, Zimmet P, Shaw J. Metabolic syndrome: A new world-wide definition: A Consensus Statement from the International Diabetes Federation. Diabe Med 2006;23:469-480.   DOI